CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
1246816-04-5 | (2S,4S)-4-(乙酰硫基)-2 - [(二甲基氨基)羰基] -1-吡咯烷羧酸4-硝基苄基酯-d6 | (2S,4S)-4-(Acetylthio)-2-[(dimethylamino)carbonyl]-1-pyrrolidinecarboxylic Acid 4-Nitrobenzyl Ester-d6 | C17H15D6N3O6S | 401.47 | | |
1246816-14-7 | 三聚氰胺-13c3,15n3 | melamine-13c3,15n3 | | | | |
1246816-23-8 | 5-乙酰氨基-6-氨基-3-甲基尿嘧啶-d3水合物 | 5-Acetylamino-6-amino-3-methyluracil-d3 Hydrate | C7H9D3N4O4 | 219.21 | | |
1246816-30-7 | 二乙基二硫代氨基甲酸甲酯-d3 | Methyl diethyldithiocarbamate-d3 | C6H10D3NS2 | 166.32 | | |
1246816-31-8 | 二甲烯胺-d3 | Dimethenamid-d3 | C12H15D3ClNO2S | 278.81 | | |
1246816-50-1 | R-(-)-Arundic Acid-d3 | | C11H19D3O2 | 189.31 | | |
1246816-57-8 | 氯苯那敏杂质a | chlorphenamine impurity a | | | | |
1246816-83-0 | 2-乙酰氨基-5-巯基-1,3,4-噻二唑-D3 | 2-Acetamido-5-mercapto-1,3,4-thiadiazole-d3 | C4H2D3N3OS2 | 178.25 | | |
1246817-13-9 | 4-乙酰丁酸-d5 | 4-Acetylbutyric Acid-d5 | C6H5D5O3 | 135.17 | | |
1246817-20-8 | Benzydamine-d6 Hydrochloride | | C19H18D6ClN3O | 351.9 | 152-156°C | |
1246817-44-6 | | dabigatran-d3 solution | | | | |
1246817-85-5 | 尼洛替尼-n-氧化物 | nilotinib n-oxide | | | | |
1246818-14-3 | 丙环唑-d7 | propiconazole-d7 | C15H10Cl2D7N3O2 | 349.26 | | |
1246818-51-8 | 普拉克索杂质11(对映异构体) | pramipexole impurity 11 (and enantiomer) | | | | |
1246818-61-0 | 2-Benzylamino-2-phenylbutanol-d5 | | C17H16D5NO | 260.39 | | |
1246818-83-6 | | tebuconazole-(tert-butyl-d9) | | | | |
1246818-88-1 | 阿托伐他汀环氧乙烷杂质 | atorvastatin oxirane impurity | | | | |
1246819-01-1 | N-异丙基卡维地洛 | N-Isopropyl Carvedilol | C27H32N2O4 | 448.55 | 116-118 °C | |
1246819-04-4 | | cimbuterol-(tert-butyl-d9) | | | | |
1246819-17-9 | Nitazoxanide D4 | | C12H5D4N3O5S | 311.31 | | |
1246819-22-6 | N-亚硝基地氯雷他定 | N-Nitroso Desloratadine | C19H18ClN3O | 339.82 | | |
1246819-43-1 | | psilocybin (d4, 98%) 100 ug/ml in acetonitrile:water (1:1) | | | | |
1246819-49-7 | ε-Aminocaproic Acid-d10 Hydrochloride | | C6H4D10ClNO2 | 177.7 | | |
1246819-50-0 | Febuxostat D9 | | C16H7D9N2O3S | 325.43 | | |
1246819-51-1 | Aminorex-d5 | | C9H5D5N2O | 167.22 | | |
1246819-55-5 | (S)-Amphetamine-d3 Hydrochloride | | C9H11D3ClN | 174.69 | | |
1246819-56-6 | 6-Amino-5-nitroso-3-methyluracil-d3 | | C5H3D3N4O3 | 173.14 | | |
1246819-58-8 | 马布特罗-d9 | mabuterol-d9 | | | | |
1246819-59-9 | 伊马替尼mpm杂质 | imatinib meta-mpm impurity | | | | |
1246819-60-2 | 3’-O-Benzyl-(1R)-hydroxy Tapentadol-d5 | | C21H24D5NO2 | 332.49 | | |
1246819-64-6 | | (-)-levamisole-d5 hydrochloride solution | | | | |
1246819-83-9 | | norlidocaine-(ethyl-d5) | | | | |
1246819-84-0 | 多韦替尼 D8 | Dovitinib-D8 | C21H13D8FN6O | 400.48 | | |
1246819-88-4 | 2-(2-Aminoethylamino)ethanol-d4 | | C4H8D4N2O | 108.18 | | |
1246819-98-6 | S-(+)-Arundic Acid-d3 | | C11H19D3O2 | 189.31 | | |
1246819-99-7 | 3-羟基地雷他定-d4 | 3-hydroxy desloratadine-d4 | | | | |
1246820-03-0 | Benzydamine-d6 N-Oxide | | C19H17D6N3O2 | 331.44 | | |
1246820-19-8 | Loxapine-d8 hydrochloride | | C18H11D8Cl2N3O | 372.32 | | |
1246820-31-4 | N-Benzy N,N-Didesmethyl Trimebutine-d5 | | C27H26D5NO5 | 454.57 | | |
1246820-35-8 | (2S,3S)-5-(2-(双(甲基-d3)氨基)乙基)-3-羟基-2-(4-甲氧基苯基)-2,3-二氢苯并[b][1,4]硫氮杂环庚烷-4(5H)-酮 | (2S,3S)-5-(2-(Bis(methyl-d3)amino)ethyl)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one | C20H18D6N2O3S | 378.52 | | 86-88 °C |
1246820-43-8 | 6-Amino-3-methyluracil-d3 | | C5H4D3N3O2 | 144.15 | | |
1246820-46-1 | n-叔丁氧羰基-n-去乙基红地那非 | n-boc-n-desethyl acetildenafil | | | | |
1246820-62-1 | Losartan (D4 Carboxylic Acid) | | C22H17D4ClN6O2 | 440.92 | | |
1246820-85-8 | 盐酸索他洛尔d6 | sotalol hydrochloride d6 | | | | |
1246820-88-1 | 苯丙甲胺-d3盐酸盐 | 2-Phenyl-N-(trideuteriomethyl)propan-1-amine:hydrochloride | C10H13ClD3N | 188.71 | | |
1246820-97-2 | 3-Amino-2,2-dimethylpropanamide-d6 | | C5H6D6N2O | 122.2 | | |
1246820-98-3 | 2-(2-Amino-5-bromobenzoyl)pyridine-d4 | | C12H5D4BrN2O | 154.23 | | |
1246829-05-9 | | (2,3-dimethyl-4-pyridinyl)boronic acid | C7H10BNO2 | 150.97 | >168 °C | 335.0±52.0 °C at 760 mmHg |
1246833-26-0 | 姜黄素-D6 | Curcumin-d6 | C21H14D6O6 | 374.42 | | |
1246833-75-9 | 普拉克索杂质bi-io460bs | pramipexole impurity bi-io460bs | | | | |